Nisoldipine

Contraindicated

Nisoldipine Ketoconazole Topical Extina® Foam Increased nisoldipine exposure Details Nisoldipine Ensitrelvir Increased CYP3A substrates exposure and an increased risk of CYP3A substrates-related adverse effects Details Nisoldipine Itraconazole Sporanox Increased nisoldipine exposure and an increased risk of nisoldipine-related adverse effects (including congestive heart failure) Details Nisoldipine Ketoconazole Extina Increased nisoldipine exposure Details Nisoldipine Levoketoconazole Recorlev Increased CYP3A4 substrate exposure and an increased risk of sensitive CYP3A4 substrate-related adverse reaction Details

Major

Nisoldipine Abametapir Increased exposure of CYP3A4 substrate Details Nisoldipine Clonidine Transdermal Patch Catapres An increased risk of worsen sinus node dysfunction and atrioventricular node conduction, an increased risk of bradycardia and AV b... Details Nisoldipine Clopidogrel Plavix Decreased antiplatelet effect and increased risk of thrombotic events Details Nisoldipine Digoxin Cardoxin® An increased risk of bradycardia and an increased risk of complete heart block Details Nisoldipine Encorafenib Braftovi Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Nisoldipine Epirubicin Ellence Increased risk of heart failure Details Nisoldipine Lacosamide Injection Motpoly An increased risk of AV block, bradycardia, and ventricular tachyarrhythmia Details Nisoldipine Lefamulin Xenleta Increased sensitive CYP3A4 substrate exposure and an increased risk of sensitive CYP3A4 substrate-related toxicities associated wi... Details Nisoldipine Lenacapavir Injection Sunlenca Increased sensitive CYP3A substrate exposure and an increased risk of sensitive CYP3A substrate-mediated adverse reactions Details Nisoldipine Lenacapavir Oral Sunlenca Increased sensitive CYP3A substrate exposure and an increased risk of sensitive CYP3A substrate-mediated adverse reactions Details Nisoldipine Letermovir Injection Prevymis Increased CYP3A substrate exposure Details Nisoldipine Melphalan Alkeran An increased risk of severe hypotension Details Nisoldipine Melphalan Injection Alkeran An increased risk of severe hypotension Details Nisoldipine Mitapivat Aqvesme Reduced CYP3A substrate exposure Details Nisoldipine Adagrasib Krazati Increased CYP3A4 substrate exposure Details Nisoldipine Apalutamide Erleada Reduced CYP3A4 substrate exposure Details Nisoldipine Atazanavir Reyataz An increased calcium channel blocker exposure Details Nisoldipine Avacopan Tavneos Increased CYP3A4 substrate exposure Details Nisoldipine Carbamazepine Carbatrol Reduced dihydropyridine calcium channel blockers and reduced efficacy of dihydropyridine calcium channel blockers Details Nisoldipine Ceritinib Zykadia Increased CYP3A substrate exposure Details Nisoldipine Clarithromycin Biaxin Increased risk of hypotension, acute kidney injury, bradyarrhythmias, lactic acidosis and peripheral edema Details Nisoldipine Clonidine Duraclon An increased risk of worsen sinus node dysfunction and atrioventricular node conduction, an increased risk of bradycardia and AV b... Details Nisoldipine Cobicistat Tybost Increased nisoldipine exposure Details Nisoldipine Conivaptan Vaprisol Increased CYP3A substrate exposure Details Nisoldipine Dabrafenib Tafinlar Reduced sensitive CYP3A4 substrate exposure Details Nisoldipine Dantrolene Dantrium Severe hyperkalemia with cardiovascular collapse Details Nisoldipine Erythromycin Erythrocin Stearate An increased calcium channel blocker that are CYP3A4 substrate exposure, an increased calcium channel blocker that are CYP3A4 subs... Details Nisoldipine Fedratinib Inrebic Increased CYP3A4 substrate exposure Details Nisoldipine Fexinidazole An increased CYP3A4 substrate exposure Details Nisoldipine Fluconazole Diflucan Increased nisoldipine exposure and an increased risk for nisoldipine toxicity Details Nisoldipine Fosnetupitant Increased exposure of CYP3A4 substrate Details Nisoldipine Fosphenytoin Cerebyx Reduced nisoldipine exposure Details Nisoldipine Lacosamide Motpoly An increased risk of AV block, bradycardia, and ventricular tachyarrhythmia Details Nisoldipine Landiolol An increased risk of myocardial contractility depression and increase the risk of bradycardia or heart block Details Nisoldipine Lenacapavir Sunlenca Increased sensitive CYP3A substrate exposure and an increased risk of sensitive CYP3A substrate-mediated adverse reactions Details